Expansion of Neisseria meningitidis Serogroup C Clonal Complex 10217 during Meningitis Outbreak, Burkina Faso, 2019
Joann F. Kekeisen-Chen
, Felix T. Tarbangdo, Shalabh Sharma, Daya Marasini, Henju Marjuki, Janelle L. Kibler, Heather E. Reese, Seydou Ouattara, Flavien H. Ake, Issaka Yameogo, Issa Ouedraogo, Emmanuel Seini, Robert L. Zoma, Issa Tonde, Mahamoudou Sanou, Ryan T. Novak
1, and Lucy A. McNamara
1
Author affiliations: Centers for Disease Control and Prevention, Atlanta, Georgia, USA (J.F. Kekeisen-Chen, S. Sharma, D. Marasini, H. Marjuki, J.L. Kibler, H.E. Reese, R.T. Novak, L.A. McNamara); Davycas International, Ouagadougou, Burkina Faso (F.T. Tarbangdo, F.H. Ake, R.L. Zoma); Ministère de la Santé, Ouagadougou (S. Ouattara, I. Yameogo, I. Ouedraogo, E. Seini); Centre Hospitalier Universitaire Pédiatrique Charles de Gaulle, Ouagadougou (I. Tonde, M. Sanou); Université Joseph Ki-Zerbo, Ouagadougou (I. Tonde, M. Sanou)
Main Article
Figure 1
Figure 1. Meningitis surveillance zones in study of expansion of Neisseria meningitidis serogroup C clonal complex 10217 during meningitis outbreak, Burkina Faso, January 28–May 5, 2019. Main map indicates Diapaga health district divided into 8 communes within Tapoa Province of Burkina Faso. Inset map indicates the location of Tapoa Province in Burkina Faso. Colors indicate subdivision of the health district into 4 epidemiologic surveillance zones that have ≈100,000 inhabitants per zone.
Main Article
Page created: December 31, 2023
Page updated: February 22, 2024
Page reviewed: February 22, 2024
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.